The Hydroxyzine Pamoate Capsules, cataloged under National Stock Number 6505-01-126-3163, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Goldline Laboratories, Inc. Dba Goldline Laboratories. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 2 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-126-3163 |
| Primary Part Number | 01-4853 |
| Item Name | Hydroxyzine Pamoate Capsules |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Goldline Laboratories, Inc. Dba Goldline Laboratories |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Capsule Primary Container Content Quantity | 1000.000 |
| Active Medicament Medicinal Strength | 50.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| 01-4853 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00182-1099-10 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
NSN 6505-01-126-3163 is a Hydroxyzine Pamoate Capsules, manufactured by Goldline Laboratories, Inc. Dba Goldline Laboratories, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-126-3163 has 2 cross-referenced part numbers: 01-4853 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00182-1099-10 (Goldline Laboratories, Inc. Dba Goldline Laboratories).
There are 2 known substitutes for 6505-01-126-3163: 5961-00-448-4595, 6145-01-138-7307. Verify interchangeability with system specifications before substitution.
Key specifications for 01-4853: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Capsule Primary Container Content Quantity: 1000.000; Active Medicament Medicinal Strength: 50.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT; Primary Container Type: BOTTLE. 4 total characteristics are documented in the Federal Logistics Information System.